Skip to main content
Fig. 4 | BMC Ophthalmology

Fig. 4

From: Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy – a systematic approach to identify and characterize data sources

Fig. 4

Number of publications per data source*. A2ASDOCT, AREDS (Age-Related Eye Disease Study) 2 Ancillary Spectral Domain Optical Coherence Tomography Study; BES, Beijing Eye Study; BMES, Blue Mountains Eye Study; LALES, Los Angeles Latino Eye Study; LUMINOUS, study to evaluate the long-term safety, efficacy, treatment patterns and health-related quality of life outcomes in patients treated with ranibizumab in routine practice; MCCS, Melbourne Collaborative Cohort Study; MESA, Multiethnic Study of Atherosclerosis; VRMNY, Vitreous Retina Macula Consultants of New York. * Data sources with more than 5 relevant publications

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us